The tyrosine phosphorylation of nephrin is reported to regulate podocyte morphology via the Nck adaptor proteins. The Pak family of kinases are regulators of the actin cytoskeleton and are recruited to the plasma membrane via Nck. Here, we investigated the role of Pak in podocyte morphology. Pak1/2 were expressed in cultured podocytes. In mouse podocytes, Pak2 was predominantly phosphorylated, concentrated at the tips of the cellular processes, and its expression and/or phosphorylation were further increased when differentiated. Overexpression of rat nephrin in podocytes increased Pak1/2 phosphorylation, which was abolished when the Nck binding sites were mutated. Furthermore, dominant-negative Nck constructs blocked the Pak1 phosphorylation induced by antibody-mediated cross linking of nephrin. Transient transfection of constitutively kinase-active Pak1 into differentiated mouse podocytes decreased stress fibers, increased cortical F-actin, and extended the cellular processes, whereas kinase-dead mutant, kinase inhibitory construct, and Pak2 knockdown by shRNA had the opposite effect. In a rat model of puromycin aminonucleoside nephrosis, Pak1/2 phosphorylation was decreased in glomeruli, concomitantly with a decrease of nephrin tyrosine phosphorylation. These results suggest that Pak contributes to remodeling of the actin cytoskeleton in podocytes. Disturbed nephrin-Nck-Pak interaction may contribute to abnormal morphology of podocytes and proteinuria. nephrin; Nck; foot process PODOCYTES SURROUND GLOMERULAR CAPILLARY LOOPS and are critical determinants of glomerular permselectivity. Their function is tightly associated with their intricate morphology, which features interdigitating foot processes from adjacent podocytes.
structural organization and regulation and have similar biological actions (3) . Pak consists of an NH 2 -terminal regulatory domain, which includes the binding domain for GTP-Rac and GTP-Cdc42, and a COOH-terminal kinase domain. Among Pak1, 2, and 3, which have the molecular size of 68, 62, and 65 kDa, respectively, Pak1 is the prototype and most extensively studied (3) . Although Pak has versatile biological actions, its main action appears to be the regulation of cytoskeletal dynamics (3). Pak1 is known to cause the disassembly of focal adhesions, and promote lamellipodia formation and membrane ruffling (11) . Of particular interest, Pak1 caused neurite outgrowth in PC12 cells (7) . However, the mechanisms of Pakmediated cytoskeletal changes are yet to be clearly elucidated. Information from genetic studies is limited; gene knockout of Pak1 in mouse resulted in immune defects, whereas Pak2 knockout was embryonically lethal (14) . Pak3 is relatively specific to the brain, and its mutation in human is known to cause X-linked, nonsyndromic mental retardation (14) .
In addition to Rac1/Cdc42, the adaptor molecule Nck is known as an upstream regulator of Pak (5) . Here, we investigated the role of the Pak family of kinases in the cytoskeletal regulation of glomerular podocytes. Results showed that Pak1 and 2 are expressed in podocytes. Pak is recruited to nephrin via Nck, a process that leads to increased Pak phosphorylation. Because phosphorylation of Pak is known to correspond to its activity (3) , this increased phosphorylation in turn is likely to contribute to actin remodeling and potentially to the formation/ extension of cellular processes in podocytes.
MATERIALS AND METHODS

Materials.
Tissue culture media, hygromycin, and lipofectamine 2000 were from Invitrogen-Life Technologies (Burlington, ON, Canada). Interferon-␥ was from Medicorp (Montreal, QC, Canada). Electrophoresis reagents were from Bio-Rad Laboratories (Mississauga, ON, Canada). Anti-nephrin antibody was obtained as described previously (23) . Other antibodies were obtained from the following sources: Pak1 (Zymed Laboratories, South San Francisco, CA); Pak1, (2, 3), Pak2, Myc (FITC-labeled), and green fluorescent protein (GFP) (Santa Cruz Biotechnology, Santa Cruz, CA); phospho-Pak for Ser199/204 of Pak1 and Ser192/197 of Pak2 (Cell Signaling, Beverly, MA); phosphotyrosine (PY69) and Nck (BD Biosciences, Mississauga, ON, Canada); synaptopodin (Progen Biotechnik, Heidelberg, Germany); Alexa Fluoro 633-phalloidin (Molecular Probes, Eugene, OR); tubulin, tetramethylrhodamine isothiocyanate-phalloidin (SigmaAldrich, Mississauga, ON, Canada). NSC23766 was from CalBiochem (San Diego, CA). Enhanced chemiluminescence detection reagents were from Amersham Bioscience (Baie d'Urfé, QC, Canada). Puromycin aminonucleoside and other chemicals were from SigmaAldrich.
Plasmids. Plasmids encoding wild-type full-length rat nephrin and rat nephrin tyrosine mutants were as described previously (23) . Mouse podocin cDNA was a gift from Dr. T. Benzing (University Hospital Freiburg, Freiburg, Germany). Myc-Pak1, GFP-Pak1 (wild-type), GFP-Pak1T423E, GFP-Pak1K299R, and GFP-Pak1 Pak inhibitor do-main (PID) were gifts from Drs. Bokoch and DerMardirossian (Scripps Institute, La Jolla, CA). GFP-Nck-SH2 and GFP-Nck-W143R were gifts from Dr. Larose (McGill University, Montreal, QC, Canada).
Cell culture. Rat glomerular epithelial cell (GEC) culture and characterization were previously described (41) . GEC stably transfected with mouse podocin alone (GEC-P) or mouse podocin and rat nephrin (GEC-P/N) were described previously (41) . GEC stably transfected with mouse podocin and rat nephrin mutant Y1127F (GEC-Y1127F) or mouse podocin and rat nephrin mutant Y1204/ 1228F (GEC-Y2F) were also established. Conditionally immortalized mouse podocytes (MPs; gift from Dr. K. Endlich, University of Heidelberg) were maintained or differentiated as described previously (9) . MP-nephrin was derived from MP by stably expressing rat nephrin cDNA using retrovirus transduction. Human embryonic kidney cell (HEK) nephrin was derived as described previously (24) . Transient transfection of HEK293T cells was performed using lipofectamine 2000 following the manufacturer's instructions. Cells were used 18 h after transfection.
Antibody-mediated cross linking of nephrin. Antibody-mediated cross linking of nephrin was performed as described previously with minor modification (24) . Briefly, cells were incubated with 10 g/ml of mAb-5-1-6 diluted in serum-free medium supplemented with buffer (0.5 M HEPES, pH 7.5) for 30 min at 4°C. Medium was discarded, and cells were cross linked with 10 g/ml of goat antimouse IgG, also diluted in serum-free medium supplemented with buffer at 37°C for the indicated times.
Immunoprecipitation and immunoblotting. Cells or glomeruli were lysed and were subjected to immunoprecipitation and/or immunoblotting as described previously (23) . Protein content was quantified using scanning densitometry (Image J software).
Nucleofection. Nucleofection was performed using Amaxa Basic Nucleofector Kit for Primary Mammalian Epithelial Cells (ESBE Scientific, Markham, ON, Canada) according to the manufacturer's instructions using the program T-23, which we found to generate the highest transfection efficiency in MP.
qPCR and PCR. Total RNA was prepared from cells using Trizol Reagent (Invitrogen). cDNA synthesis was performed using a QuantiTect Reverse Transcription kit (Qiagen, Mississauga, ON, Canada). The PCR primer set used for Pak2 were forward, aacctttgccttctgttcca; reverse, aacatggatggtgtgctcaa. qPCR was carried out with iTaq SYBR Green Supermix with a passive reference dye ROX (Bio-Rad) and an ABI 7300 using the ⌬Ct method with GAPDH as an endogenous control. For conventional PCR, the same primer sets were used for Pak2. Primers for Pak1 were as follows: forward, ggctccttgacagatgtggt; reverse, tgtccctgtgaatgacttgg. Primers for Pak3 were as follows: forward, tcattgcaccaagaccagag; reverse, gtggtggaattggcattctc.
Induction of puromycin aminonucleoside nephrosis and isolation of rat glomeruli. Puromycin aminonucleoside nephrosis (PAN) was induced, and rat glomeruli were isolated as described previously (1) . Studies were approved by the Animal Care Committee at McGill University. Urine was collected for 24 h in metabolic cages, and urine protein concentration was determined by Bio-Rad Protein Assay Kit.
Immunohistochemistry. Immunohistochemistry was performed as we described previously (1) using rabbit anti-Pak (1:100 dilution; SC-881, Santa Cruz). Normal rabbit IgG (negative control) showed no staining, and the Pak staining was blocked by the specific peptide antigen (not shown).
Rac activation assay. Rac1 activity was measured using a G-LISA kit (BK125; Cytoskeleton, Denver, CO) according to the manufacturer's instructions.
Immunofluorescent staining and quantification of actin assembly. Immunostaining was performed as described previously (40) except that cover slips were coated with type I collagen for MPs. Images were obtained with a confocal microscope (Fluoview FV1000, OLYMPUS, Tokyo, Japan). To quantify the actin assembly of transfected cells, transfected cells were randomly selected and F-actin fluorescence images were acquired with the confocal microscope. Cell membranes and membrane protrusions were outlined on the fluorescence image with a width of 2 m ("membrane region"). The average fluorescence intensity (mean pixel density) in the membrane region and remaining cytosol region were quantified using Olympus Fluoview (Ver. 1.7a). The fluorescence intensities were collected from 20 -22 different cells per group.
Pak2 knockdown. shRNAs for mouse Pak2 were designed using a web-based program (www.genscript.com). Three shRNAs were cloned into RNATin-H1.2/Neo (GenScript) and stably transfected into MP-nephrin using Nucleofection. Only one sequence (tentatively named C: GATCCCGTGATTGGCTGATAAAGGATCTTTGATATCCGAGA-TCCTTTATCAGCCAATCATTTTTTCCAAAAGCT) gave effective knockdown of Pak2.
Data analysis. Data are presented as the means Ϯ SE. The t-test was used to determine significant differences between two groups. One-way ANOVA was used to determine significant differences among groups. When significance was found, the Tukey honestly significant difference test was used for post-ANOVA pair-wise comparisons.
RESULTS
Expression of Pak isoforms in podocytes.
To test the hypothesis that the Pak family of kinases contributes to the regulation of the actin cytoskeleton in glomerular podocytes, we first studied the expression of Pak isoforms in podocytes in culture. By immunoblotting, undifferentiated MPs showed a clear band corresponding to the reported molecular size of Pak2 (62 kDa) and doublets of approximately the reported size of Pak1 (68 kDa) (Fig. 1A) . Similarly, cultured rat GEC and normal rat glomerular lysates both showed bands corresponding to Pak1 and Pak2. Antibody specific to Pak1 recognized the doublets of ϳ68 kDa, indicating that both bands represent Pak1. Expression of Pak1/2 in MPs, rat GEC, and rat glomeruli was also confirmed by RT-PCR (36 cycles for Pak1, 32 cycles for Pak2, Fig. 1B ). Pak3 mRNA was not detected at 36 cycles but was detected at 41 cycles in rat GEC and MPs but not in rat glomerulus (Fig. 1B) . Taken together, these findings indicate that Pak1 and Pak2 are expressed in cultured podocytes and rat glomerulus but that the level of Pak3 expression is very low in cultured cells and negligible in rat glomerulus.
We next studied the expression of Pak in the rat kidney. Immunofluorescence staining was not successful using the commercially available Pak antibodies; therefore definitive costaining of Pak with the known podocyte markers was not possible. Nonetheless, by immunohistochemistry, Pak staining was observed both in the tubules and glomerulus (Fig. 1C) . It is well established that podocytes are located at the periphery of the glomerular tufts in rodents (13) . In Fig. 1C , several cells positive for Pak are localized at the periphery of the glomerular tufts, clearly outside the open capillary lumen (arrow), localization consistent with that of podocytes. Therefore, it is reasonable to assume that at least some of the podocytes express Pak in vivo. Immunoblotting and RT-PCR of the two known podocyte cell lines also support this assumption (Fig. 1, A and B) .
Expression and phosphorylation of Pak2 is increased with differentiation in MPs. It is well established that cultured MPs can be induced into a more differentiated phenotype (30) . This phenotypic change typically includes the expression of differentiation markers such as synaptopodin and nephrin, as well as reorganization of the actin cytoskeleton (30) . We next studied the temporal expression profiles of the Pak isoforms in differentiating MPs. By immunoblotting, Pak2 expression was significantly increased when podocytes were differentiated for 1-2 wk ( Fig. 2A) . In contrast, Pak1 expression decreased significantly after 2 wk of differentiation ( Fig. 2A) .
Activation of Pak kinase is known to induce autophosphorylation (39) . Ser 199/204 of Pak1 and Ser 192/197 of Pak2 are located in the aminoterminal inhibitory domain, and autophosphorylation of these residues is thought to prevent the kinase from reverting to an inactive conformation (22) . Pak2 was clearly phosphorylated at Ser 192/197 in undifferentiated MPs, and the phosphorylation increased further when cells were differentiated (Fig. 2B ), suggesting that Pak2 is not only upregulated in differentiated podocytes but its activity is also increased with differentiation. In contrast, Pak1 phosphorylation was much weaker and did not change significantly through all the differentiation stages (Fig. 2B) .
We next studied the intracellular distribution of Pak2 in differentiating MPs. In undifferentiated podocytes, Pak2 was localized at the tips of the short cellular processes. In differentiated podocytes, cellular processes were further extended and Pak2 staining was localized at the tips of cellular processes and at the edges of lamellipodia (Fig. 2C) .
Pak is recruited to nephrin. It was shown previously that the cytoplasmic domain of nephrin becomes tyrosine phosphorylated and recruits the adaptor protein Nck (15, 24, 38) . Given that Nck binds to the Pak family of kinases via its second SH3 domain (5), we next investigated whether Pak occurs in the same protein complex as nephrin. In the subsequent series of experiments, which required Pak transfection, we utilized the Pak1 plasmid instead of the Pak2 plasmid owing to the markedly low expression of the latter, which made the experiments technically difficult. When HEK-nephrin cells (HEK293T cells stably transfected with rat nephrin, Ref. 24) were transfected with Pak1 (GFPtagged), nephrin coimmunoprecipitated with Pak1 only when the extracellular domain of nephrin was cross linked with antibodies, a maneuver known to induce the tyrosine phosphorylation of nephrin (24) . This cross linking-dependent association of nephrin and Pak1 was markedly attenuated when the two tyrosine residues in nephrin responsible for Nck binding were mutated to phenylalanine (Y1204/ 1228F or Y2F; Ref. 24) (Fig. 3A) . We also verified whether Pak is recruited to nephrin with the use of immunofluorescence staining. When HEK-nephrin cells were transfected with Pak1, Pak1 was distributed diffusely in the cytoplasm. When cells were subjected to antibody-mediated nephrin cross linking, in contrast, Pak1 formed aggregates, which colocalized with the site of nephrin cross linking (Fig. 3B ). This effect was abolished when the nephrin mutant Y2F was used (Fig. 3B) . These results suggest that Pak1 is recruited into the protein complex, which also includes nephrin, in a tyrosine phosphorylation-dependent manner, likely via Nck.
We next investigated whether Pak also forms a molecular complex with nephrin in vivo, using normal rat glomerular lysates. When Nck was immunoprecipitated with anti-Nck antibody, both nephrin and Pak were coimmunoprecipitated (Fig. 3C) , supporting the idea that nephrin-Nck-Pak form a protein complex in vivo. Whereas the Pak1 bands were consistently recognized in the precipitates, the precipitation of Pak2 could not be consistently confirmed (Fig. 3C) . Taken together, these findings support the idea that the intracellular domain of nephrin recruits Pak in a tyrosine phosphorylationand Nck-dependent manner. Nephrin increases Pak phosphorylation. We next asked whether the recruitment of Pak to nephrin leads to the phosphorylation of Pak. Using our previously established subclones of rat GEC, which stably overexpress wild-type rat nephrin together with podocin (GEC-P/N) (41), we found that nephrin was tyrosine phosphorylated without exogenous stimuli, albeit weakly (41) . We then compared these subclones to control GEC, which overexpress only podocin (GEC-P, Ref. 41) , to see whether the expression of tyrosine-phosphorylated nephrin contributed to the phosphorylation of Pak, utilizing the phospho-specific Pak antibody. After being normalized to their expression levels, both Pak1 and Pak2 were more strongly phosphorylated in GEC-P/N than GEC-P, likely suggesting their activation (Fig. 4A) . Rac1 is a known activator of Pak (3) and is known to be activated by nephrin (41) . When GEC-P/N were incubated with NSC23766 (200 M) for 16 h, as in Fig.  4A , Rac1 activity was inhibited by 43 Ϯ 12% (N ϭ 5), but the increased Pak phosphorylation in GEC-P/N was not affected (Fig. 4A) . These results suggest that Rac1 may not be a major pathway of Pak phosphorylation via nephrin. However, because the Rac1 inhibition was only partial in these cells, further studies, such as Rac1 knockdown, are required to determine the role of Rac1 definitively.
Of interest, when the Y2F mutant of nephrin was expressed in the place of wild-type nephrin (GEC-Y2F), Pak1/2 phosphorylation was markedly reduced, compared with GEC-P/N (Fig. 4A) . These results were confirmed with two additional clones each of GEC-P/N and GEC-Y2F, excluding the possi- bilities of clonal variations (not shown). In contrast, another nephrin mutant, Y1127F, did not have a significant impact on Pak1/2 phosphorylation (Fig. 4A) . These results suggest that tyrosine-phosphorylated nephrin contributes to Pak phosphorylation, likely via Nck.
In addition, antibody-mediated cross linking of the extracellular domain of nephrin in MPs expressing nephrin (MPnephrin) led to increased phosphorylation of Pak1/2 (Fig. 4B) . Taken together, nephrin increases Pak phosphorylation both in rat GEC and MPs, likely in a tyrosine phosphorylation-dependent manner. Fig. 4A presents a role of Nck in nephrin-mediated Pak activation, we next addressed the role of Nck in Pak phosphorylation induced by nephrin. We cotransfected Pak1 and two dominant-negative mutants of Nck, GFP-NckSH2 (containing only the SH2 domain of Nck, which fails to bind to any of the effectors) or GFP-NckW143R (with a mutation in the second SH3 domain, which fails to bind to Pak) (17, 27) into HEK-nephrin cells and induced nephrin tyrosine phosphorylation by antibodymediated cross linking. Cross linking markedly increased Pak1 phosphorylation in the absence of the Nck dominant negatives (Fig. 5) , consistent with the previous results (Fig.  4B ). Pak1 phosphorylation was markedly blunted by GFPNckSH2 and GFP-NckW143R (Fig. 5) , supporting the idea that Nck is essential to Pak phosphorylation induced by nephrin. Fig. 4 . Nephrin increases Pak phosphorylation. A: GEC were stably transfected with podocin alone (GEC-P), podocin and wild-type rat nephrin (GEC-P/N), podocin and nephrin mutant Y1127F (GEC-Y1127F), or podocin and nephrin mutant Y1204/1228F (GEC-Y2F). After 16 h of serum starvation, cells were treated or not treated with NSC23766 (Rac1 inhibitor, 200 M) for 16 h and then lysed and subjected to IB as in Fig. 2B . Densitometric analysis is shown at the bottom. Values were normalized to the protein expression and to GEC-P/N. *P Ͻ 0.01 vs. GEC-P/N, N ϭ 3. Pak1/2 phosphorylation was increased in GEC-P/N, compared with GEC-P or GEC-Y2F. p-Pak in GEC-P/N was not affected by the Rac1 inhibitor. B: MPs were stably transfected with rat nephrin (MP-N) and subjected to antibody-mediated cross linking. Cells were lysed and subjected to IB as in Fig 2B. Pak2 phosphorylation was markedly increased after cross linking, peaking at 2 min. Pak1 phosphorylation was also increased, albeit weakly. Densitometric analysis is shown at the bottom. Values were normalized to the protein expression and to control (0 min). ϩP Ͻ 0.05 vs. 0 min, N ϭ 3.
Pak phosphorylation induced by nephrin cross linking is blocked by dominant-negative Nck mutants. Given that
Pak modulates F-actin assembly in podocytes.
The Pak family of kinases is a known regulator of the actin cytoskeleton (3) . To test the role of Pak in the cytoskeletal regulation in podocytes, we first utilized transient transfection of Pak plasmids. Transient transfection of constitutively kinase-active Pak1 (PakT423E)(34) into differentiated podocytes decreased transcellular stress fibers and increased cortical F-actin (Fig. 6) . In contrast, kinase-dead mutant (K299R) (36) , which acts as a dominant negative of Pak kinases, increased transcellular stress fibers and decreased cortical F-actin (Fig. 6) . A kinase inhibitory construct (PID) (39) had a similar impact as the kinasedead mutant (Fig. 6) . To quantify the above changes, we measured the ratio of F-actin fluorescence intensities in the membrane (subcortical) and cytosol regions (MATERIALS AND METHODS). The ratio was increased significantly in PakT423E-transfected cells but was decreased in cells transfected with K299R or PID (Fig. 6 ). In addition, we observed that the processes in PakT423E-transfected cells were more prominent than in the control because their length after leaving the cell body tended to be long, whereas those in dominant negative (DN)/PID-transfected cells tended to be short. These results suggest that Pak contributes to actin reorganization in podocytes and that this effect is, at least in part, dependent on kinase activity.
Pak is required for normal morphology of differentiated podocytes. As shown above, the kinase-dead (dominant-negative) mutant of Pak caused aberrant morphology of MPs. To further confirm the role of Pak in podocyte morphology and cytoskeleton, we generated subclones of MPs that stably expressed Pak2 shRNA. Of the three shRNAs tested, one significantly reduced the level of Pak2 mRNA by around 60% (Fig. 7A) . The protein level was also reduced (Fig. 7A) . Cell morphology was examined at 2 wk of differentiation; in control cells stably transfected with vector alone (also encoding GFP), Pak2 localized along the cellular processes (Fig. 7B) , similar to untransfected cells (Fig. 2) , whereas, in Pak2-knockdown cells, Pak2 expression was markedly diminished and cells showed HEK-nephrin cells were cotransfected with myc-Pak1 and GFP alone, GFP-NckSH2 (which fails to bind to any of the effectors), or GFP-NckW143R (which fails to bind to Pak). After cross linking cells were lysed and subjected to IB as in Fig. 2B . Pak1 phosphorylation was increased on cross linking of nephrin; however, this effect was abolished by GFP-NckSH2 and GFP-NckW143R. C, control (mock cross linking). Note that the molecular size of Pak is ϳ70 kDa because of the myc tag. more intense trans-cellular stress fibers and shorter cell processes. The ratio of F-actin fluorescence intensities in the membrane (subcortical) and cytosol regions was decreased in Pak2-knockdown cells (Fig. 7C) . Thus the effects of Pak2 knockdown were similar to those of the DN/PID of Pak (Fig. 6) , supporting the role of Pak in actin reorganization in podocytes.
Pak phosphorylation is decreased in rats with PAN. We previously reported that, in the rat model of PAN, in which podocyte injury leads to foot process effacement and heavy proteinuria (18) , tyrosine phosphorylation of nephrin is decreased, accompanied by the dissociation of nephrin and its molecular partners such as Nck and the regulatory unit of phosphatidylinositide kinase (PI3K) (24, 41) . Because nephrin-mediated Pak phosphorylation appears to be dependent on Nck, at least in part, we next tested whether Pak phosphorylation is altered in rats with PAN. After a single intravenous injection of puromycin aminonucleoside, heavy proteinuria was observed on day 7 (control, 9 Ϯ 3 mg/day; PAN, 299 Ϯ 45 mg/day; P Ͻ 0.01, N ϭ 8 rats each). On day 14, proteinuria started to decline (160 Ϯ 47 mg/day; P Ͻ 0.05 vs. day 7, N ϭ 8 rats each). In the lysates of normal rat glomeruli, Pak1/2 were clearly phosphorylated, albeit weakly, suggesting that Pak1/2 are weakly active in normal glomeruli. Pak1/2 phosphorylation was decreased on days 4 and 7 and returned to normal on day 14, whereas the expression level of Pak1/2 was unchanged (Fig. 8) . The timing of the decrease in Pak1/2 phosphorylation corresponded to decreased tyrosine phosphorylation of nephrin (Fig. 8) .
DISCUSSION
Nephrin is a slit diaphragm protein, which is critical to the structural and functional integrity of podocytes. It was previously shown that tyrosine-phosphorylated nephrin recruits the Nck adaptor proteins (15, 24, 38) , and that myristylated Nck-SH3-II domain (which binds to Pak) can activate Pak1 in the absence of GTP-Rac and Cdc42, whereas unmyristylated Nck-SH3-II or myristylated but Pak1-binding-defective Nck-SH3-II did not activate Pak1 (26) . By analogy, it is likely that tyrosinephosphorylated nephrin recruits Pak to the plasma membrane via Nck, leading to its phosphorylation and activation. In rat, we showed that Y1204 and Y1228 are responsible for Nck binding (25) and that these two residues are therefore likely to contribute to Pak recruitment. In support of this, the Y2F mutant of nephrin failed to recruit (Fig. 3, A and B) or to increase phosphorylation of Pak (Fig. 4A) . Although we confirmed that Y1127 did not contribute to Pak phosphorylation (Fig. 4A) , the role of other tyrosine residues in Pak activation is yet to be investigated. We and others previously reported that nephrin is tyrosine phosphorylated under normal conditions (15, 24) . This finding was recently confirmed using phospho-specific antibodies of nephrin, which recognize the Nck binding sites of nephrin (Y1204 and Y1228 in rat nephrin) (16, 37) . It is therefore likely that signal transduction via nephrin-Nck-Pak is relevant in normal podocyte morphology and function.
Regulation of Pak1 is complex, and multiple mediators have been shown to activate the protein. The serine/threonine kinase phosphoinositide-dependent kinase 1 (PDK1) was shown to phosphorylate human Pak1 at Thr423, which increases Pak1 activity (19) . We previously reported that nephrin recruits PI3-kinase upon tyrosine phosphorylation (41) , which would likely increase the local concentration of the product of PI3-kinase, leading to the recruitment of the pleckstrin homology domain of PDK1 and its activation (8) . On this basis, one possible scenario is that Pak is recruited to nephrin via Nck, bringing Pak to the proximity to active PDK1, which phosphorylates and activates Pak. Alternatively, Pak may be activated by lipids such as sphingosine in a GTPase-independent manner, as reported previously (4, 33) .
Transfection of active Pak in podocytes resulted in an increase in subcortical F-actin and decrease in cytosolic stress fibers, accompanied by longer cellular processes, whereas the inhibition/knockdown of Pak had the opposite effects (Figs. 6  and 7 ). The significance of these changes in cultured podocytes in the context of podocyte physiology and pathology in vivo can only be speculated. In the neurite growth cone, increased F-actin assembly at the tip has been found to be important for neurite growth (10) . Similarly, F-actin assembly in the subcortical areas of podocytes might be important for process extension. In fact, cells in which Pak activity was reduced generally showed shorter cellular processes (Figs. 6 and 7 ).
Pak1 and Pak2 share 91% sequence identity within their kinase domains, suggesting their redundant functions (32) . Indeed, both Pak1 and Pak2 are expressed in many tissue types and phosphorylate a number of common substrates, including Bad, Raf, Mek, and Merlin (32) . In some instances, however, Pak1 and Pak2 may have differential roles. For example, knockdown of Pak1 in tumor cells increased cofilin phosphorylation, whereas that of Pak2 increased myosin light chain phosphorylation (6) . Also, Pak2, but not Pak1, is essential for the viability of mice (14) . We acknowledge that overexpres- Fig. 8 . Pak phosphorylation is altered in puromycin aminonucleoside nephrosis (PAN). PAN was induced by a single injection of puromycin aminonucleoside. Glomeruli were isolated on days 4, 7, and 14, and lysates were subjected to immunoblotting for phosphoPak1/2, Pak 1, 2, and 3, or were immunoprecipitated by nephrin antibody and blotted for pY69 and nephrin. Note that nephrin runs as doublets likely because of differential glycosylation, and pY-nephrin corresponds to the upper band (23) . Heavy proteinuria was observed on day 7 but started to decline on day 14. Pak 1/2 phosphorylation was decreased on day 4 and day 7, coinciding with a decrease in nephrin tyrosine phosphorylation but returned to normal on day 14. *P Ͻ 0.01 vs. control (Cntl), ϩP Ͻ 0.05 vs. D7 (day 7), N ϭ 8.
sion of kinase-dead or other mutant Pak proteins might override the isoform specificities; nonetheless, the effects of Pak1 DN/PID were similar to those of Pak2 knockdown (Figs. 6 and 7) , suggesting that the two isoforms may have similar effects on actin assembly in podocytes. Interestingly, increased cofilin phosphorylation and myosin light chain phosphorylation, caused by knockdown of Pak1 and Pak2, respectively (6), both contributed to the increase in stress fibers observed in the present study when Pak expression/activity was inhibited (Figs. 6 and 7) . It is therefore possible that Pak1 and Pak2 act in concert in podocytes. The differential roles of Pak1 and Pak2 in podocytes require further investigations.
The present study did not address the mechanisms by which Pak modulates the actin cytoskeleton in podocytes. It was previously reported that Pak1 is essential to lamellipodial stability (35) . Because the lamellipodium is a key structural feature of the motile tips of growing processes (20, 21) , it is possible that Pak promotes process extension via the stabilization of lamellipodia. LIM-kinase is a major substrate of Pak and is known to regulate the activity of the actin-severing protein cofilin. Although complex, the regulation of LIMkinase/cofilin activities is mediated by Pak and other signaling molecules (3). Of particular interest, it was shown that both excessive or insufficient cofilin activity disturbs neurite extension in PC12 cells, suggesting that the tight regulation of cofilin activity is critical for neurite extension (10) . We previously reported that GEC-P/N have greater cofilin activity (lower cofilin phosphorylation) than GEC-P (41). How Pak regulates cofilin activity in GEC-P/N requires further investigation.
In the rat model of PAN, the decrease in Pak phosphorylation coincided with the decrease in nephrin tyrosine phosphorylation (Fig. 8) . Although the exact location where the change of Pak phosphorylation occurred was not determined, because podocyte is the major site of cell injury in PAN (18, 31) , it is reasonable to assume that the changes occurred mainly in podocytes. It is therefore likely that the dissociation of Nck from nephrin secondary to nephrin dephosphorylation leads to the dissociation of Pak from nephrin and dephosphorylation of Pak. Decreased phosphorylation of Pak and nephrin were obvious on day 4 before the proteinuria started, continued on day 7 when the proteinuria reached the peak, and started to resolve on day 14. Given this time course, it is tempting to speculate that decreased Pak phosphorylation/activity in podocytes may contribute to foot process effacement and proteinuria in PAN and that Pak phosphorylation/activity starts to increase as the podocytes start to recover from the injury. Because Pak1 knockout mice have no obvious renal phenotype and Pak2 knockout mice are embryonic lethal (14) , a more sophisticated approach, such as podocyte-specific gene targeting of Pak2 combined with Pak1 knockout, will be needed to further define the role of Pak in podocyte morphology and function in vivo.
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